Terminologies de Santé (Publiées par l'ANS)
0.1.0 - ci-build
Terminologies de Santé (Publiées par l'ANS)
0.1.0 - ci-build
Terminologies de Santé (Publiées par l'ANS) - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Retired as of 2023-04-04 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="1.2.250.1.213.1.1.5.353"/>
<meta>
<versionId value="1"/>
<lastUpdated value="2024-12-19T05:05:27.078+00:00"/>
<profile
value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet 1.2.250.1.213.1.1.5.353</b></p><a name="1.2.250.1.213.1.1.5.353"> </a><a name="hc1.2.250.1.213.1.1.5.353"> </a><a name="1.2.250.1.213.1.1.5.353-fr-FR"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 1; Last updated: 2024-12-19 05:05:27+0000</p><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/R4/shareablevalueset.html">Shareable ValueSet</a></p></div><ul><li>Include these codes as defined in <code>1.3.6.1.4.1.19376.1.8.2.1</code><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>640</td><td>pT0 [--]: No evidence of primary tumor</td></tr><tr><td>641</td><td>pT1a [IA]: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings</td></tr><tr><td>642</td><td>pT1b [IB]: Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings</td></tr><tr><td>643</td><td>pT1c [IC]: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings</td></tr><tr><td>644</td><td>pT2a [IIA]: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings</td></tr><tr><td>645</td><td>pT2b [IIB]: Extension to other pelvic tissues. No malignant cells in ascites or peritoneal washings</td></tr><tr><td>646</td><td>pT2c [IIC]: Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant cells in ascites or peritoneal washings</td></tr><tr><td>647</td><td>pT3a [IIIA]: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)</td></tr><tr><td>648</td><td>pT3b [IIIB]: Macroscopic peritoneal metastasis beyond pelvis <= 2 cm in greatest dimension</td></tr><tr><td>649</td><td>pT3c [IIIC]: Peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis</td></tr></table></li></ul></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod">
<valuePeriod>
<start value="2021-03-15T00:00:00+01:00"/>
</valuePeriod>
</extension>
<url
value="https://smt.esante.gouv.fr/fhir/ValueSet/1.2.250.1.213.1.1.5.353"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:1.2.250.1.213.1.1.5.353"/>
</identifier>
<version value="20230404000000"/>
<name value="JDV_Ovaire_pT_CISIS"/>
<title value="JDV_Ovaire_pT_CISIS"/>
<status value="retired"/>
<experimental value="false"/>
<date value="2023-04-04T00:00:00+01:00"/>
<publisher
value="Agence du Numérique en Santé(ANS) -2 - 10 Rue d'Oradour-sur-Glane, 75015 Paris"/>
<description value="JDV_Ovaire_pT_CISIS"/>
<compose>
<include>
<system value="1.3.6.1.4.1.19376.1.8.2.1"/>
<concept>
<code value="640"/>
<display value="pT0 [--]: No evidence of primary tumor"/>
</concept>
<concept>
<code value="641"/>
<display
value="pT1a [IA]: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings"/>
</concept>
<concept>
<code value="642"/>
<display
value="pT1b [IB]: Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings"/>
</concept>
<concept>
<code value="643"/>
<display
value="pT1c [IC]: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings"/>
</concept>
<concept>
<code value="644"/>
<display
value="pT2a [IIA]: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings"/>
</concept>
<concept>
<code value="645"/>
<display
value="pT2b [IIB]: Extension to other pelvic tissues. No malignant cells in ascites or peritoneal washings"/>
</concept>
<concept>
<code value="646"/>
<display
value="pT2c [IIC]: Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant cells in ascites or peritoneal washings"/>
</concept>
<concept>
<code value="647"/>
<display
value="pT3a [IIIA]: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)"/>
</concept>
<concept>
<code value="648"/>
<display
value="pT3b [IIIB]: Macroscopic peritoneal metastasis beyond pelvis <= 2 cm in greatest dimension"/>
</concept>
<concept>
<code value="649"/>
<display
value="pT3c [IIIC]: Peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis"/>
</concept>
</include>
</compose>
</ValueSet>